Wedbush reiterated their outperform rating on shares of Nuvalent (NASDAQ:NUVL – Free Report) in a research note released on Friday morning, Benzinga reports. Wedbush currently has a $99.00 price objective on the stock. Other analysts have also issued reports about the stock. Jefferies Financial Group started coverage on shares of Nuvalent in a research note […]